The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.

There is a tendency to overlook the multiple factors and stakeholders that contributed to the Rx opioid crisis. This includes ...

"This case involves an unlawful price-fixing agreement among several PBMs—orchestrated by the PBM rate aggregator, GoodRx—to ...

Analyst Allen Lutz of Bank of America Securities reiterated a Sell rating on GoodRx Holdings (GDRX – Research Report), reducing the price ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

Current legislation before Congress, including the Modernizing and Ensuring PBM Accountability Act (S.2973) and the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023 (S.3430), ...

Panelists emphasized the need for transparency and policy reforms in pharmacy benefit management (PBM) to improve ...

The usual PBM strategy cuts an independent pharmacy's share of the prescription revenue to just 3 cents per pill dispensed, ...

Glenn Irwin has signed a two-year deal to remain with the PBM Ducati team to compete in the 2025 and 2026 British Superbike ...

One exception that enjoys bipartisan support, however, is the effort to rehab the drug supply chain. It’s currently dominated ...

The Valeda Light Delivery System is for the treatment of patients with dry age-related macular degeneration (AMD).